An ambitious push to create a “Global Pandemic Center” in suburban Maryland got a $500,000 boost Tuesday from the Montgomery County Council, which said the project could help drive the county’s post-pandemic economic recovery and foster resilience against the next major health crisis.
Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine GAITHERSBURG, Md., May 3, 2021 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today [….]
Montgomery County, Maryland, was a leader in biotechnology before COVID-19 hit, ranking among the highest in the nation for the number of life sciences companies, and the pandemic has only fueled the industry’s growth.
BioIT Solutions Develops Mobile Application for COVID-19 Testing for Cambridge Consortium April 5, 2021 – Silver Spring, MD. BioIT Solutions announced that it has developed and launched a mobile application [….]
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, GSK and the UK Government Vaccines Taskforce announced that they have reached an agreement in principle to support manufacturing of up to 60 million doses of Novavax’ COVID-19 vaccine candidate (NVX-CoV2373) for use in the UK. GSK will provide ‘fill and finish’ manufacturing capacity at its Barnard Castle facility in the North East of England beginning as early as May 2021, with a rapid technology transfer between the two companies beginning immediately. GSK and Novavax will negotiate a final agreement to include additional terms and conditions.
Germantown’s QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio
QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio GERMANTOWN, Md. & HILDEN, Germany–(BUSINESS WIRE)– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Emergency [….]
MCEDC awards almost $100,000 to early growth-stage biotech companies to help with small wet lab buildout
Germantown’s Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
Germantown’s Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP) GERMANTOWN, Md., March 23, 2021 /PRNewswire/ — Precigen, Inc., a biopharmaceutical company specializing in the development [….]
Hood College to Partner with Kite Pharma to Train Employees for a New Facility in Urbana Hood College plans to partner with a pharmaceutical company to train employees for a [….]
Students returning to Towson University for spring term will find that campus has grown by 320,000 square feet.
The Science Complex is now TU’s largest academic structure—significantly larger than Smith Hall’s 220,000 square feet. It includes 50 teaching laboratories, 30 research laboratories, 50 classrooms, eight lecture halls, 10 collaborative student spaces, an outdoor classroom leading to the Glen Arboretum, a rooftop greenhouse complex, a new planetarium and an observatory.
“The completion of the new science complex marks the result of years of planning and effort from our faculty, staff and partners, including the University System of Maryland Board of Regents, Chancellor Jay A. Perman, Governor Larry Hogan and our state legislative leaders, who have shown unwavering support to this affirmation of TU’s impact on Maryland,” says President Kim Schatzel. “This impressive complex will bolster TU’s nationally-recognized STEM programming, and will enhance TU’s capacity to fulfill its promise as an anchor institution, supplying prepared leaders to meet Maryland’s workforce demands.”Read the full article at: www.towson.edu